Hg Capital: invests in HHAeXchange
Hg, the Manager of HgCapital Trust plc (“HGT”), today announces an investment in HHAeXchange (“HHAX” or the “Company”), the leading provider of homecare management solutions for payers, providers, and state Medicaid agencies. Terms of the deal are not disclosed.
HgCapital Trust plc will invest approximately £24.0 million in HHAX, with other institutional clients of Hg investing alongside HGT through the Hg Genesis 9 Fund.
HGT, whose shares are listed on the London Stock Exchange, gives private and institutional investors the opportunity to participate in all Hg’s investments.
Note that these figures only relate to HGTs share of Hg’s overall investment in HHAX.
HGT’s liquid resources available for future deployment (including all announced transactions, the interim dividend payable in October and equity raised via tap issuance) are estimated to be £172 million (10% of the pro-forma 31 August 2021 NAV of £1.65 billion).
The investment will reduce HGT’s outstanding commitments to invest in Hg transactions to approximately £511 million (31% of the pro-forma 31 August 2021 NAV).
HHAeXchange and healthcare investor Cressey & Company welcome strategic investment from software investor, Hg, to accelerate continued growth as the leading homecare management solution provider
Partnership builds on HHAeXchange’s exponential growth and enhances its ability to scale its best-in-class enterprise management and homecare workflow solutions.
HHAeXchange (“HHAX” or the “Company”), the leading provider of homecare management solutions for payers, providers, and state Medicaid agencies, announced today that it has secured a new investment from Hg, a leading global investor in software and services.
Cressey & Company LP (“Cressey”), a leading healthcare-focused private investment firm which first partnered with HHAX in 2018, will continue to be a significant investor in HHAX. Both investors will share joint governance of the business.
Greg Strobel, CEO of HHAeXchange, said: “We are proud to welcome Hg to the team for this next chapter of HHAeXchange’s continued success. With Hg’s track record of growing technology businesses and Cressey’s specialist background in the healthcare space, HHAeXchange is incredibly well-positioned to enhance our solution suite and expand our reach to meet the growing demand for home and community-based services.”
Founded in 2008, HHAX offers a comprehensive software as a service (SaaS) platform to its customers that improves patient outcomes, drives operational efficiency and increases compliance across the homecare ecosystem. Its solutions are delivered through subscription-based enterprise and mobile tools and facilitate over 125 million annual visits for 650,000 caregivers across more than 44 states. Today, HHAX has global offices across North America, Europe, and Asia.
Nick Crowne, Principal at Hg, said: “HHAX provides a best-in-class SaaS platform to the homecare industry, with a vital mission to enable high-quality care in home and community-based settings. We’re excited to partner with a stellar team at both HHAX and Cressey to advance the Company’s mission and support its continued growth.”
David Issott, Partner at Hg, said: “Hg has a strong focus on healthcare technology, with HHAX being our sixth current healthcare technology business across Europe and North America and our second investment in the sector in just the last few weeks, meaning Hg will have invested well over $1.5bn in the sector globally. We look forward to bringing this experience to the table and are delighted to partner with Greg, as well as the entire HHAX and Cressey teams.”
“We are thrilled to welcome Hg as our and HHAX’s new partner, as the Company continues executing on its strategic plan and strengthening its leadership position in the homecare sector,” added Dave Rogero, Partner at Cressey.
The terms of the transaction have not been disclosed. William Blair & Company advised HHAX and Cressey on the transaction. Lincoln International LLC were advisers to Hg.
Below is a short animated clip which provides highlights of the recent interim results